Study identifier:SD-005-0414
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the effect of Long-term treatment with Rhinocort Aqua (Budesonide) Nasal Spray in Children with Perennial Allergic Rhinitis.
Perennial Allergic Rhinitis
Phase 4
No
Budesonide, Placebo
All
209
Interventional
4 Years - 10 Years
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: 1 Budesonide | - |
Placebo Comparator: 2 | - |